Product Description
Nitrazepam 5mg
Nitrazepam (brand names like Mogadon or Insom) is a benzodiazepine medication primarily used as a hypnotic (sleep aid) for short-term treatment of severe insomnia in adults. The 5mg dose is a common strength for tablets.
Key Uses
- Insomnia: Helps initiate and maintain sleep, especially when other treatments fail.
- Other indications (less common, varies by country): Adjunct for epilepsy (e.g., myoclonic seizures), anxiety, or muscle spasms.
- Duration: Typically prescribed for 7-14 days max to avoid dependence; not for long-term use.
Dosage Guidelines (Adults)
| Condition | Typical Dose | Notes |
|---|---|---|
| Insomnia | 5-10mg at bedtime | Start with 5mg; elderly/start low at 2.5-5mg. Max 10mg/night. |
| Epilepsy (adjunct) | 5-10mg at night | Up to 15-30mg/day in divided doses (specialist use). |
| Children (rare) | 0.5-5mg (age-dependent) | Not first-line; pediatric use limited. |
- Administration: Swallow whole with water, at bedtime. Avoid alcohol, grapefruit, or other sedatives.
- Onset: 30-60 minutes; duration 6-8 hours (long-acting).
Side Effects
| Common (mild) | Serious (seek medical help) |
|---|---|
| Drowsiness, dizziness, confusion | Severe allergic reaction (rash, swelling), breathing issues, hallucinations, memory loss |
| Dry mouth, headache | Dependence/withdrawal (anxiety, seizures after abrupt stop) |
| Next-day hangover | Paradoxical effects (agitation, aggression – rare) |
- Overdose risk: High with alcohol/opioids; symptoms include coma, respiratory depression. Naloxone ineffective; seek emergency care.
Warnings & Precautions
- Addiction risk: High potential for tolerance, dependence, withdrawal (taper off slowly).
- Contraindications: Sleep apnea, severe respiratory issues, myasthenia gravis, acute porphyria, pregnancy (category D – fetal harm), breastfeeding.
- Interactions: Potentiates CNS depressants (alcohol, opioids, other benzos, antidepressants). Avoid with CYP3A4 inhibitors (e.g., ketoconazole).
- Driving/operating machinery: Impairs next day; legal restrictions in many countries.
- Special populations:
| Group | Adjustments |
|---|---|
| Elderly | Reduce dose (liver/kidney decline); higher fall/fracture risk. |
| Liver/Kidney impairment | Dose reduction; monitor closely. |
| Pregnancy | Avoid; risk of floppy infant syndrome. |
Evidence & Facts
- Pharmacology: GABA-A receptor agonist; half-life ~18-30 hours (active metabolite nitrazepam).
- Efficacy: Effective short-term per meta-analyses (e.g., Cochrane review: improves sleep latency by ~20 mins vs. placebo).
- Regulation: Prescription-only (Schedule IV in US; Class C in UK). Abuse potential noted by DEA/WHO.
- Alternatives: Non-benzo options like zolpidem, melatonin agonists (ramelteon), or CBT-I for insomnia.
This is general information from sources like FDA, EMA, BNF, and PubMed (e.g., studies PMID: 24635450). Not medical advice – consult a doctor/pharmacist for personal use, as individual factors vary. Misuse can be dangerous.
Additional Information
| Quantity | 100 Pills(5mg), 200 Pills(5mg), 100 Pills(10mg), 200 Pills(10mg) |
|---|



